Retard formulation for pralnacasan

Details Retard formulation for pralnacasan Retard formulation for pralnacasan

A - Human Necessities

61

K

A61K 9/20 (2006.01) A61K 9/00 (2006.01)

Patent

CA 2624838

The inventive retard tablets comprising at least two layers, wherein at least one layer rapidly releases a drug 1S 9S (RS, 3S) N-(2-Ethoxy-5-oxo- tetrafuran- 3-yl)-6, 10-dioxo-9-(isochinolin-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10- octahydro- 6-H-pyridazino [1 , 2-a] [1, 2] diazepin-1-carboxamide and/or the salts or derivatives thereof and/or acids released therefrom and at least one layer releases a drug 1S, 9S (RS, 3S) N-(2-Ethoxy-5-oxo-tetrafuran-3-yl)-6,10- dioxo-9-(isochinolin-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10-octahydro-6-H- pyridazino [1, 2-a] [1, 2] diazepin-1-carboxamide and/or the salts or derivatives thereof and/or acids released therefrom in a delayed manner for treating autoimmune diseases, type I and type II diabetes, rheumatoid arthritis, osteoarthritis and/or psoriasis

L'invention concerne des comprimés à effet retard comprenant au moins deux couches, ces comprimés étant caractérisés en ce qu'au moins une couche libère rapidement le médicament 1S, 9S (RS, 3S) N-(2-éthoxy-5-oxo-tétrafurane-3-yl)-6,10-dioxo-9-(isoquinoléine-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10-octahydro-6-H-pyridazino [1, 2-a] [1, 2] diazépine-1-carboxamide et/ou ses sels ou dérivés et/ou les acides libres de ceux-ci et en ce qu'au moins une couche libère le médicament 1S, 9S (RS, 3S) N-(2-éthoxy-5-oxo-tétrafurane-3-yl)-6,10-dioxo-9-(isoquinoléine-1-oyl-amino)-1, 2, 3, 4, 7, 8, 9, 10-octahydro-6-H-pyridazino [1, 2-a] [1, 2] diazépine-1-carboxamide et/ou ses sels ou dérivés et/ou les acides libres de ceux-ci de façon différée pour traiter des maladies auto-immunes, le diabète de type I et de type II, la polyarthrite rhumatoïde, l'ostéoarthrite et/ou le psoriasis.

Affiliated with

Also associated with

Rating

Retard formulation for pralnacasan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retard formulation for pralnacasan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retard formulation for pralnacasan will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1698501